Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
Kamila Janusz, M. Izquierdo, Félix López Cadenas, Fernando Ramos, Jesús María Hernández-Sánchez, Eva Lumbreras, Cristina Robledo, Javier Sánchez del Real, Juan Carlos Caballero, Rosa Collado, Teresa Bernal, Carme Pedro, A. Insunza, Raquel de Paz, Blanca Xicoy, Eduardo Salido, Joaquín Sánchez‐García, Sandra Santos Mínguez, Cristina Miguel García, Ana María Simón Muñoz, Mercedes Sánchez‐Barba, Jesús María Hernández‐Rivas, María Abáigar, María Díez‐Campelo
Topics & Concepts
ConcomitantInternal medicineMedicineMutationMyelodysplastic syndromesHematologyGene mutationGastroenterologyOncologyMyeloidGeneGeneticsBiologyBone marrowAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia Treatments